Filing Details
- Accession Number:
- 0001104659-22-067758
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-02 20:00:41
- Reporting Period:
- 2022-06-01
- Accepted Time:
- 2022-06-02 20:00:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1425205 | Iovance Biotherapeutics Inc. | IOVA | Biological Products, (No Disgnostic Substances) (2836) | 753254381 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1719678 | G Frederick Vogt | C/O Iovance Biotherapeutics, Inc. 825 Industrial Road, 4Th Floor San Carlos CA 94070 | Interim Ceo & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-06-01 | 1,000 | $6.44 | 1,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
